The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 119, Issue 11, Pages 1351-1359
Publisher
Springer Nature
Online
2012-05-09
DOI
10.1007/s00702-012-0815-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Flibanserin attenuates l-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
- (2011) Manfred Gerlach et al. JOURNAL OF NEURAL TRANSMISSION
- Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson’s disease: a behavioral and neurochemical study in reserpinized mice
- (2010) Mattia Volta et al. JOURNAL OF NEUROCHEMISTRY
- Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter
- (2010) Karl Strecker et al. JOURNAL OF NEUROLOGY
- Multifunctional Pharmacology of Flibanserin: Possible Mechanism of Therapeutic Action in Hypoactive Sexual Desire Disorder
- (2010) Stephen M. Stahl et al. Journal of Sexual Medicine
- Decreased RGS9 protein level in the striatum of rodents undergoing MPTP or 6-OHDA neurotoxicity
- (2010) Lin-Lin Yin et al. NEUROSCIENCE LETTERS
- Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model
- (2009) Ana Muñoz et al. EXPERIMENTAL NEUROLOGY
- Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats
- (2009) Rakesh Kumar et al. NEUROPHARMACOLOGY
- Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia
- (2009) Yukinori Nagakura et al. PAIN
- Dopamine receptors and l-dopa-induced dyskinesia
- (2009) Amandine Berthet et al. PARKINSONISM & RELATED DISORDERS
- Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats
- (2009) C. Marin et al. PSYCHOPHARMACOLOGY
- Imidazoline I1 receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease
- (2008) Mitsuo Tanabe et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Levodopa-induced dyskinesias and their management
- (2008) Francesca Sorbo et al. JOURNAL OF NEUROLOGY
- 1-Adrenoceptors Mediate Dihydroxyphenylalanine-Induced Activity in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaques
- (2008) N. P. Visanji et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Invited Article: Nervous system pathology in sporadic Parkinson disease
- (2008) H. Braak et al. NEUROLOGY
- Motor coordination deficits in mice lacking RGS9
- (2007) Jacqueline Blundell et al. BRAIN RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started